Top news of the week from The American Journal of Pharmacy Benefits.
Chronic obstructive pulmonary disease (COPD) patients may face various exacerbations that may affect their daily lives with the disease through symptoms. Read more.
A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission. Read more.
Allergan has issued a voluntary recall in the United States for a single lot of its norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules (Taytulla) physician sample packs. Read more.
Those with hypertension had roughly 2.5 times more inpatient costs, almost twice the outpatient cost, and roughly triple the prescription medication cost annually. Read more.
The American Cancer Society (ACS) has updated its colorectal cancer (CRC) screening guidelines to lower the age at which individuals are recommended to begin screening. Read more.